Drug intelligence / Profile preview

Sashas Blend

Development stage
Unknown
Lead developer
Interpath Global
Administration
Oral
01

Overview

Sashas Blend is a veterinary nutraceutical developed by Interpath Global, specifically formulated to support canine joint health and mobility. It is composed of a proprietary blend of marine concentrates, including Green Lipped Mussel (Perna canaliculus), Abalone (Haliotis iris), and Shark Cartilage. These ingredients provide a rich source of glycosaminoglycans (GAGs) such as chondroitin sulfate, as well as omega-3 fatty acids (including eicosatetraenoic acids) and essential minerals. The supplement works by providing the structural building blocks for cartilage repair, inhibiting inflammatory mediators like prostaglandins and leukotrienes through the modulation of cyclooxygenase and lipoxygenase pathways, and improving synovial fluid viscosity. It is primarily used to manage symptoms of osteoarthritis and degenerative joint disease in dogs.

Brand names
Sashas BlendSashas Flex
Other names
Sashas Blend for Dogs
02

Targets

COXALOX5 (Arachidonate 5-lipoxygenase)Gag (HIV-1 Gag polyprotein)

Beyond the preview

Go deeper on Sashas Blend.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sashas Blend.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call